Clinical Trials in France — Country Dashboard | 4,497 EU Studies

Filter these 4,497 trials by condition, phase, sponsor and more.

Open in Search →

4,497 Registered trials

1,845 Recruiting

2,148 Completed trials

905 Sponsors active

1,193 Research sites

Phase III

Phase II

Phase III: 1870 Phase II/III: 208 Phase II: 1262 Phase I/II: 286 Phase III/IV: 51 Phase IV: 173 Phase I: 239 Phase I (Other): 177 Phase I (FiH): 218 Other: 8 Other: 5

Oversight events in trials active here:

104 serious breaches 882 temporary halts 92 urgent safety measures 105 unexpected events 179 corrective measures across 542 trials

View oversight register →

Top conditions

Non-small cell lung cancer 154 Non-small cell lung cancer metastatic 52 Colorectal cancer 39 Ovarian cancer 37 Squamous cell carcinoma of head and neck 32 Systemic lupus erythematosus 30 Endometrial cancer 28 Breast cancer 28 Non-small cell lung cancer stage IV 27 Myelodysplastic syndrome 27 Diffuse large B-cell lymphoma 26 Triple negative breast cancer 26

Top sponsors

Assistance Publique Hopitaux De Paris 264 Centre Hospitalier Universitaire De Nantes 195 Merck Sharp & Dohme LLC 177 Novartis Pharma AG 165 F. Hoffmann-La Roche AG 144 AstraZeneca AB 143 Janssen - Cilag International 115 AbbVie Deutschland GmbH & Co. KG 97 Sanofi-Aventis Recherche & Developpement 72 Glaxosmithkline Research & Development Limited 66 Bristol-Myers Squibb Services Unlimited Company 65 Unicancer 65

Cities with most trials

All 448 cities →

All trials — page 27

4,497 total

An Early Phase Clinical Trial to Evaluate COM701 in Relapsed Platinum Sensitive Ovarian Cancer (PSOC) Recruiting

2025-521125-33-00 Phase I/II Ovarian Cancer Compugen Ltd.
Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 Recruiting

2024-518144-20-00 Phase I (FiH) Primary Hyperoxaluria Type 1 (PH1) Arbor Biotechnologies Inc.
Selective Treatment of Oral Povorcitinib Long-Term Rollover Study (STOP-LTR) Recruiting

2024-520107-12-00 Phase III Hidradenitis Suppurativa // Prurigo Nodularis // Vitiligo Incyte Corp.
Medical-scientific study of dasatinib and venetoclax for children with relapsed or refractory leukemia or lymphoma with a mutation in the MA… Recruiting

2022-501866-22-00 Phase I/II Acute Lymphoblastic Leukemia, in Relapse Lymphoblastic Lymph… Princess Maxima Center For Pediatric Oncology
The AIRTIVITY TM Study: A study to find out whether BI 1291583 helps people with bronchiectasis Recruiting

2024-518589-29-00 Phase III Bronchiectasis Boehringer Ingelheim Espana S.A.; Boehringer Ingelheim International GmbH
COLCOT-T2D Recruiting

2024-516646-19-00 Phase III Type 2 diabetic patients with no prior cardiovascular (CV) e… Montreal Heart Institute
Sotorasib combined with first-line chemotherapy for advanced pancreatic adenocarcinoma Recruiting

2024-516233-12-00 Phase I (Other) Advanced pancreatic adenocarcinoma Asociacion Grupo Tratamiento De Tumores Digestivos
A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia … Recruiting

2024-512753-24-00 Phase III Acute Myeloid Leukemia (AML) Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Study to evaluate efficacy and safety of inclisiran in children aged 2 to under 12 years of age with homozygous familial hypercholesterolemi… Recruiting

2024-514595-41-00 Phase III homozygous familial hypercholesterolemia Novartis Pharma AG
A Phase 1b, Open-Label Study of CLN-978 for the Treatment of Active, Moderate to Severe Sjogren’s Disease Recruiting

2025-521462-96-00 Phase I (Other) Sjogren's Disease Cullinan Therapeutics Inc.
A Study of YL201 in Patients With Advanced Solid Tumors Recruiting

2024-517589-41-00 Phase I Advanced solid tumors Medilink Therapeutics (Suzhou) Co. Ltd.
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult P… Recruiting

2023-505479-56-00 Phase I Follicular lymphoma (FL) AbbVie Deutschland GmbH & Co. KG
A Study to Investigate the Safety and Efficacy of Pirtobrutinib in Adults with Immune Thrombocytopenia Recruiting

2024-518502-40-00 Phase I/II Immune Thrombocytopenia Eli Lilly & Co.
A Phase 1, Open-Label Dose Escalation and Expansion study of SNV1521 in Participants with Advanced Solid Tumors Recruiting

2025-520557-36-00 Phase I Advanced Solid Tumors Synnovation Therapeutics Inc.
A randomized, placebo-controlled trial to evaluate the safety and efficacy of Debio 4126 in patients with acromegaly previously treated with… Recruiting

2024-516616-24-00 Phase III Acromegaly Debiopharm International S.A.
A study to determine how safe MB-CART2019.1 is and how well it works in children and adolescents with B cell neoplasms Recruiting

2023-506348-17-00 Phase II Relapsed/refractory (r/r) mature B cell neoplasms who have r… Miltenyi Biomedicine GmbH
A study to test the safety and efficacy of EP102 in patients with advanced solid tumours Recruiting

2025-521305-40-00 Phase I Participants with Advanced Solid Tumors Epics Therapeutics
AFFIRM: A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Pri… Recruiting

2024-516525-31-01 Phase III Primary Biliary Cholangitis Gilead Sciences Inc.
CARLA-M19 : “Prospective non-randomized phase I/II study investigating the safety of CD19 CAR-T cells in patients with refractory/relapsed A… Recruiting

2023-509212-29-01 Phase I/II Patients (male or female) ≥18 years old with R/R AML that ex… Centre Hospitalier Universitaire De Lille
A Study to Learn About the Study Medicine Called Sigvotatug Vedotin in People with Locally Advanced, Unresectable, or Metastatic Non-Small C… Recruiting

2024-517968-36-00 Phase III non-small cell lung cancer Pfizer Inc.
A Phase 3, Randomized, Open-Label Study of Axatilimab Versus Best Available Therapy in Participants With Chronic Graft-Versus-Host Disease A… Recruiting

2024-518973-32-00 Phase III Chronic Graft-Versus-Host Disease Incyte Corp.
First in human, Phase 1a/1b Study of KM-023 in healthy volunteers and Olmsted syndrome patients Recruiting

2025-521446-20-00 Phase I Olmsted syndrome Orvida Pharma Ltd.
Phase 2, Multicenter, Open label, Platform Study investigating Tarlatamab (AMG 757) in patients with Metastatic/Locally Advanced Small-Cell … Recruiting

2024-515847-47-00 Phase II Metastaic small cell lung cancer (SCLC) and other poorly dif… Institut Gustave Roussy
A phase 2/3, multi-center, study of L-Annamycin in combination with cytarabine vs. placebo in combination with cytarabine as second line the… Recruiting

2024-518359-47-00 Phase II/III Acute Myeloid Leukemia Moleculin Biotech Inc.

Showing 625–648 of 4,497 trials

← All countries